Summit Therapeutics PLC is a biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the discovery and development of innovative treatments for infectious diseases. Leveraging its proprietary drug development platforms, Summit focuses on addressing significant unmet medical needs across its strategic operations in the United States, Latin America, and Europe. The company is committed to advancing patient care by delivering transformative therapies that improve the quality of life for individuals afflicted with severe infections.